The Chronic Lymphocytic Leukemia Channel is supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
EHA 2019 | CLL & CAR-T: the intricacies and potential
David Maloney
• 14 Jun 2019
David Maloney, MD, PhD, Fred Hutchinson Cancer Research Center, Seattle, WA, discusses the use of CAR T-cell therapy in chronic lymphocytic leukemia (CLL) and the potential of the treatment at the 24th Congress of the European Hematology Association (EHA) 2019, held in Amsterdam, Netherlands.
